An Unusual Case of Lorlatinib-Induced Pneumonitis: A Case Report

We describe the case of a 73-year-old female with metastatic ALK-positive NSCLC who developed subacute dyspnoea 3 weeks after commencinglorlatinib. She was diagnosed with drug-induced pneumonitis, from which she recovered clinically following the cessation of her targeted therapy. Pneumonitis related tolorlatinib is a rare pulmonary toxicity, and early recognition and intervention is critical to reduce the associated risks of respiratory failure and death.Case Rep Oncol 2022;15:225 –230
Source: Case Reports in Oncology - Category: Cancer & Oncology Source Type: research